ADRs Close Lower; Fanhua Slips 16%
This article was automatically generated by MarketWatch using technology from Automated Insights.
International stocks trading in New York closed lower Friday, as the S&P/BNY Mellon index of American depositary receipts fell 1.1% to 161.55.
The European index lost 1.5% to 156.35. The Asian index fell 0.7% to 185.78. The Latin American index declined 0.6% to 217.80, while the emerging-markets index edged 0.2% lower to 307.17.
Fanhua, based in China, posted the largest decline, sliding 16% to $5.25, followed by shares of China's Hywin Holdings, which tumbled nearly 15% to $2.37. Shares of United Kingdom-based TC BioPharm tumbled 13% to $2.58.
France's Biophytis was the biggest leader during the session, rocketing nearly 32% to 85 cents, and Peru-based Compania de Minas Buenaventura soared 25% to $12.50. Studio City International Holdings, which is based in Hong Kong, rounded out the top three leaders on Friday, with shares soaring 24% to $6.68.
Data source: Dow Jones Market Data, FactSet.
(END) Dow Jones Newswires
December 15, 2023 16:52 ET (21:52 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks